Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
2(7%)
Results Posted
33%(4 trials)
Terminated
2(7%)

Phase Distribution

Ph phase_2
5
17%
Ph phase_3
4
14%
Ph not_applicable
12
41%
Ph phase_4
8
28%

Phase Distribution

0

Early Stage

5

Mid Stage

12

Late Stage

Phase Distribution29 total trials
Phase 2Efficacy & side effects
5(17.2%)
Phase 3Large-scale testing
4(13.8%)
Phase 4Post-market surveillance
8(27.6%)
N/ANon-phased studies
12(41.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

12 of 16 finished

Non-Completion Rate

25.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

29

all time

Status Distribution
Active(4)
Completed(12)
Terminated(4)
Other(9)

Detailed Status

Completed12
unknown9
Withdrawn2
Recruiting2
Not yet recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
29
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (17.2%)
Phase 34 (13.8%)
Phase 48 (27.6%)
N/A12 (41.4%)

Trials by Status

withdrawn27%
unknown931%
completed1241%
recruiting27%
not_yet_recruiting27%
terminated27%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT06572761Phase 3

A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor

Not Yet Recruiting
NCT02518594Phase 3

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix

Completed
NCT02913495Phase 4

Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth

Completed
NCT07415070Not Applicable

Effectiveness of Targeted Cervical Length Screening Guided by a Preterm Birth Risk Scoring System in Reducing the Rate of Preterm Birth

Not Yet Recruiting
NCT06463652Not Applicable

Cerclage With Progesterone Versus Progesterone Only in Singleton Pregnancies

Recruiting
NCT06875752Phase 4

Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles

Recruiting
NCT03251729Phase 4

Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix

Completed
NCT02460302Phase 2

Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy

Withdrawn
NCT03863613Not Applicable

Pessary Versus Cerclage With or Without Progesterone in Twins

Terminated
NCT04161989Not Applicable

Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses

Completed
NCT05276531Not Applicable

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

Completed
NCT03734770Not Applicable

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support

Completed
NCT00579553Not Applicable

Comparing IM vs. Vaginal Progesterone for Pre-term Birth

Completed
NCT04300322Not Applicable

Pessary Versus Progesterone in Singletons

Unknown
NCT02970552Phase 4

Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth

Completed
NCT03779451Not Applicable

Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa

Unknown
NCT03781466Not Applicable

Effect of Cervical Cerclage With Vaginal Progesterone in Asymptomatic Twin Pregnancies With a Sonographic Short Cervix

Unknown
NCT03633175Phase 2

Progesterone in Patients With Placenta Previa

Unknown
NCT03537287Phase 2

Different Types of Progesterone in the Prevention of Preterm Labor

Unknown
NCT03077633Phase 2

Cerclage for Twins With Short Cervix

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
29